Seeking Alpha EN

Codexis GAAP EPS of $0.11 beats by $0.14, revenue of $38.9M beats by $3.07M

Mar 11, 2026 &03241111202631; 20:24 UTC seekingalpha.com Trending 2/5

Read original on seekingalpha.com ↗

↗

Positive for markets

Sentiment score: +75/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Codexis delivered strong Q3 results with GAAP EPS of $0.11 beating expectations by $0.14 and revenue of $38.9M exceeding estimates by $3.07M, signaling robust operational performance and market demand. This significant earnings beat demonstrates the company's ability to execute and manage costs effectively.

AI CONFIDENCE

85% Very high

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↑

CDXS

CDXSStock

Expected to rise

Strong earnings beat on both EPS and revenue metrics indicates operational excellence and potential for positive stock price reaction

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Consider initiating or adding to CDXS positions on this positive earnings surprise. Monitor for guidance updates and analyst upgrades in the coming days, as significant beats often precede upward revisions.

KEY SIGNALS

EPS beat of 127% above expectationsRevenue beat of 8.6% above consensusProfitability achievement in GAAP termsStrong execution on cost management

SECTORS INVOLVED

BiotechnologySpecialty ChemicalsIndustrial Enzymes

Analysis generated on Mar 12, 2026 at 00:19 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Codexis GAAP EPS of $0.11 beats by $0.14, revenue of $38.9M beats by $3.07M

RELATED INTELLIGENCE